#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy
Click to read the study in JAMA Surgery.
Click to read the study in JAMA Surgery.
Click to read the study in JAMA Surgery.
1. Adjuvant nivolumab significantly improved disease-free survival compared to placebo among patients with resected esophageal or gastroesophageal junction cancer. 2. ...
1. A hybrid minimally invasive esophagectomy approach (Ivor-Lewis esophagectomy) was found to have lower rates of intraoperative and postoperative complications ...
1. A hybrid minimally invasive esophagectomy approach (Ivor-Lewis esophagectomy) was found to have lower rates of intraoperative and postoperative complications ...
1. Hot tea consumption in combination with excessive smoking or alcohol use was associated with a higher risk for esophageal ...
1. In a retrospective review of over 600 patients that underwent esophageal cancer surgery, there was no significant association between ...
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life While the administration of chemotherapy in end-stage ...
1. In a prospective cohort trial of over 3000 volunteers who live in areas with high incidence of esophageal cancer, ...
1. Extent of resection and preoperative tumor depth were significant predictors of improved 3- and 5-year survival in patients who ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.